(Press-News.org) Scientists at Washington University School of Medicine in St. Louis have helped identify many of the biomarkers for Alzheimer's disease that could potentially predict which patients will develop the disorder later in life. Now, studying spinal fluid samples and health data from 201 research participants at the Charles F. and Joanne Knight Alzheimer's Disease Research Center, the researchers have shown the markers are accurate predictors of Alzheimer's years before symptoms develop.
"We wanted to see if one marker was better than the other in predicting which of our participants would get cognitive impairment and when they would get it," said Catherine Roe, PhD, research assistant professor of neurology. "We found no differences in the accuracy of the biomarkers."
The study, supported in part by the National Institute on Aging, appears in Neurology.
The researchers evaluated markers such as the buildup of amyloid plaques in the brain, newly visible thanks to an imaging agent developed in the last decade; levels of various proteins in the cerebrospinal fluid, such as the amyloid fragments that are the principal ingredient of brain plaques; and the ratios of one protein to another in the cerebrospinal fluid, such as different forms of the brain cell structural protein tau.
The markers were studied in volunteers whose ages ranged from 45 to 88. On average, the data available on study participants spanned four years, with the longest recorded over 7.5 years.
The researchers found that all of the markers were equally good at identifying subjects who were likely to develop cognitive problems and at predicting how soon they would become noticeably impaired.
Next, the scientists paired the biomarkers data with demographic information, testing to see if sex, age, race, education and other factors could improve their predictions.
"Sex, age and race all helped to predict who would develop cognitive impairment," Roe said. "Older participants, men and African Americans were more likely to become cognitively impaired than those who were younger, female and Caucasian."
Roe described the findings as providing more evidence that scientists can detect Alzheimer's disease years before memory loss and cognitive decline become apparent.
"We can better predict future cognitive impairment when we combine biomarkers with patient characteristics," she said. "Knowing how accurate biomarkers are is important if we are going to some day be able to treat Alzheimer's before symptoms and slow or prevent the disease."
Clinical trials are already underway at Washington University and elsewhere to determine if treatments prior to symptoms can prevent or delay inherited forms of Alzheimer's disease. Reliable biomarkers for Alzheimer's should one day make it possible to test the most successful treatments in the much more common sporadic forms of Alzheimer's.
###
Funding for this study was provided by the Longer Life Foundation; the National Institute of Neurological Disorders and Stroke (P30 NS057105); the National Institute on Aging (P50 AG005681, P01 AG003991, and P01 AG026276); Fred Simmons and Olga Mohan, and the Charles and Joanne Knight Alzheimer's Research Initiative of the Washington University Knight Alzheimer's Disease Research Center.
Roe CM, Fagan AM, Grant EA, et. al. Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later. Neurology, DOI 10.1212/WNL.0b013e3182918ca6
Washington University School of Medicine's 2,100 employed and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is one of the leading medical research, teaching and patient care institutions in the nation, currently ranked sixth in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.
Alzheimer's markers predict start of mental decline
2013-05-14
ELSE PRESS RELEASES FROM THIS DATE:
Engineered biomaterial could improve success of medical implants
2013-05-14
It's a familiar scenario – a patient receives a medical implant and days later, the body attacks the artificial valve or device, causing complications to an already compromised system.
Expensive, state-of-the-art medical devices and surgeries often are thwarted by the body's natural response to attack something in the tissue that appears foreign. Now, University of Washington engineers have demonstrated in mice a way to prevent this sort of response. Their findings were published online this week in the journal Nature Biotechnology.
The UW researchers created a synthetic ...
Pitt chemists demonstrate nanoscale alloys so bright they could have potential medical applications
2013-05-14
PITTSBURGH—Alloys like bronze and steel have been transformational for centuries, yielding top-of-the-line machines necessary for industry. As scientists move toward nanotechnology, however, the focus has shifted toward creating alloys at the nanometer scale—producing materials with properties unlike their predecessors.
Now, research at the University of Pittsburgh demonstrates that nanometer-scale alloys possess the ability to emit light so bright they could have potential applications in medicine. The findings have been published in the Journal of the American Chemical ...
Human disease leptospirosis identified in new species, the banded mongoose, in Africa
2013-05-14
The newest public health threat in Africa, scientists have found, is coming from a previously unknown source: the banded mongoose.
Leptospirosis, the disease is called. And the banded mongoose carries it.
Leptospirosis is the world's most common illness transmitted to humans by animals. It's a two-phase disease that begins with flu-like symptoms. If untreated, it can cause meningitis, liver damage, pulmonary hemorrhage, renal failure and death.
"The problem in Botswana and much of Africa is that leptospirosis may remain unidentified in animal populations but contribute ...
Mining the botulinum genome
2013-05-14
The toxin that causes botulism is the most potent that we know of. Eating an amount of toxin just 1000th the weight of a grain of salt can be fatal, which is why so much effort has been put into keeping Clostridium botulinum, which produces the toxin, out of our food.
The Institute of Food Research on the Norwich Research Park has been part of that effort through studying the bacteria and the way they survive, multiply and cause such harm. In new research, IFR scientists have been mining the genome of C. botulinum to uncover new information about the toxin genes.
There ...
Studies support population-based efforts to lower excessive dietary sodium intakes
2013-05-14
WASHINGTON -- Recent studies that examine links between sodium consumption and health outcomes support recommendations to lower sodium intake from the very high levels some Americans consume now, but evidence from these studies does not support reduction in sodium intake to below 2,300 mg per day, says a new report from the Institute of Medicine.
Despite efforts over the past several decades to reduce dietary intake of sodium, a main component of table salt, the average American adult still consumes 3,400 mg or more of sodium a day – equivalent to about 1 ½ teaspoons ...
A better way to prevent child abuse
2013-05-14
New research at The University of Nottingham is calling for changes to a government scheme which engages community nurses in the prevention of child abuse and neglect in the home as part of a maternal and child health care programme.
The study, published online by the Journal of Public Health, has found that despite being set up to help reduce the numbers of child abuse cases, the £10 million Family Nurse Partnership will only be able to tackle around 10% of families involved in child maltreatment.
And, the researchers say, by using different, less common risk factors ...
New BUSM study explores providers' perceptions of parental concerns about HPV vaccination
2013-05-14
(Boston) – A new Boston University School of Medicine (BUSM) study has found that low-income and minority parents may be more receptive to vaccinating their daughters against Human Papillomavirus (HPV), while white, middle-class parents are more likely to defer the vaccination. The findings appear online in the May issue of the Journal of Health Care for the Poor and Underserved.
Cervical cancer incidence and mortality are markedly higher for low-income and minority women due to higher rates of HPV and limited access to screening and treatment. Vaccination for HPV has ...
Racial minorities live on the front lines of heat risk, study finds
2013-05-14
Berkeley — Some racial groups are more likely to bear the brunt of extreme heat waves because of where they live, according to a new study by researchers at the University of California, Berkeley.
The findings, published today (Tuesday, May 14) in the journal Environmental Health Perspectives, highlight racial disparities at a time when the frequency and intensity of extreme heat waves is expected to increase with climate change.
Researchers used satellite imagery data to identify areas where there is no tree canopy to provide shade, and where half or more of the ...
First analysis of dental therapists finds increase in access for children, low-income adults
2013-05-14
Boston, MA, May 14, 2013—A new report assessing the economic viability of services provided by practicing midlevel dental providers in the U.S. shows that they are expanding preventive dental care to people who need it most: children and those who can't afford care. At the same time, they are providing that care at a reduced cost to the dental practice. The report, released today by Community Catalyst, determined that midlevel dental providers currently practicing in Alaska and Minnesota cost their employers 27 and 29 percent respectively of the revenue they generate.
The ...
Passenger car drivers are more likely to die in crashes with SUVs, regardless of crash ratings
2013-05-14
BUFFALO, N.Y. – Most consumers who are shopping for a new car depend on good crash safety ratings as an indicator of how well the car will perform in a crash. But a new University at Buffalo study of crashes involving cars and sport utility vehicles (SUVs) has found those crash ratings are a lot less relevant than vehicle type.
The study is being presented May 16 at the annual meeting of the Society of Academic Emergency Medicine in Atlanta.
In head-on collisions between passenger cars and SUVs, the UB researchers found that drivers in passenger cars were nearly 10 ...